Nature Reviews Clinical Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2022-04-14 赛华佗

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：癌症;肿瘤;综述
经验分享：这个杂志高不可攀呀！！

256 0

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

引言和讨论之间有什么区别？

233 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-29 衣谷

讨论一般分几段？

260 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-03-02 sunliang

nature旗下为何办这么多review的子刊？

355 0

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-03-02 sunliang

有必要吗？sunliang 2019-03-02 00:00:00 发表:
nature旗下为何办这么多review的子刊？

sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？

409 0

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2018-05-20 ms8472206870533718

人类病毒致病传播链致癌中医药治愈.
自2016.02.25.首上传

330 0

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2018-05-20 ms5469518383470847

审稿速度:1.0
经验分享：人类病毒致病传播链致癌中医药治愈.
自2016.02.25.首上传

331 0

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2018-05-20 ms8843322981934364

人类病毒致病传播链致癌中医药治愈.
自2016.02.25.首上传

340 0

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2018-05-20 ms1357963030559907

人类病毒致病传播链致癌中医药治愈.
自2016.02.25.首上传

350 0

[GetPortalCommentsPageByObjectIdResponse(id=1211069, encodeId=c763121106919, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：癌症;肿瘤;综述 经验分享：这个杂志高不可攀呀！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Thu Apr 14 09:21:36 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102531, encodeId=ecc3110253124, content=引言和讨论之间有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102532, encodeId=308a1102532dd, content=讨论一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=260, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567507, encodeId=873c56e50701, content=nature旗下为何办这么多review的子刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567508, encodeId=c99556e50861, content=有必要吗？sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, beContent=sunliang 2019-03-02 00:00:00 发表: nature旗下为何办这么多review的子刊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843225, encodeId=6a2a843225e9, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e1d5414047, createdName=ms8472206870533718, createdTime=Sun May 20 01:42:00 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843224, encodeId=474f8432247c, content=审稿速度:1.0 经验分享：人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=331, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sun May 20 01:41:59 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843223, encodeId=b939843223dd, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=340, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60585414036, createdName=ms8843322981934364, createdTime=Sun May 20 01:41:58 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843222, encodeId=43c0843222e8, content=人类病毒致病传播链致癌中医药治愈. 自2016.02.25.首上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=350, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7465414051, createdName=ms1357963030559907, createdTime=Sun May 20 01:40:28 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544527, encodeId=de4654452ecf, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-16 gu_8183

谁能预测明年会有多少分?

523 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务